JAN 2026
VerIQ Launches as a new UK-based clinical translation platform to fast-track medtech innovation in the UK
07/01/2026
by VerIQ
London, UK — 7th January 2026 — VerIQ Limited, a UK-based medtech clinical trial accelerator, and the University of Warwick, one of the UK’s leading research universities, have announced the spinout of the new company to transform how medical device and health technology trials are designed and delivered.
The new company is designed to accelerate the design, initiation and delivery of Medtech clinical research.
VerIQ announced its spin-out from the University of Warwick to transform how medical device and health technology clinical trials are designed, initiated and delivered across the UK.
Formed in partnership with University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, VerIQ is combining Warwick Medical School’s world-leading academic and clinical research expertise, providing an integrated national clinical trial platform that enables faster, higher-quality, and more cost-efficient evaluation of novel medical technologies.
“The UK has the talent, infrastructure, and regulatory framework to lead the world in medtech innovation,” said Dr Joe Dupere, Chief Executive Officer of VerIQ Limited. “VerIQ will transform proven research excellence into an agile commercial platform, helping to ensure that life-changing technologies reach patients faster, without compromising scientific integrity.”
“When having surgery, our patients want access to the best technology available,” added Andy Metcalfe Chief Medical Officer, UHCW orthopaedic surgeon and Warwick Medical School Professor, “We need to deliver world-class studies that makes the UK the first place to come to for medical innovation. VerIQ will deliver efficient, high-quality medical research to ensure that patients get access to new technologies quickly and safely, improving their care and outcomes.”
“VerIQ harnesses the success and strength of our scientific leadership and showcases the impact that academic–industry collaboration can achieve,” said Dr Tim Hart, Director of Warwick Innovations. “By enabling this new company to commercially leverage Warwick’s existing capabilities and expertise, we can help position the region and UK at the forefront of global Medtech innovation and evidence generation.”
VerIQ’s nationwide, funded clinical trial network together with Warwick’s world-class academic and clinical research expertise is built to enable faster, higher-quality, and more cost-efficient evaluation of novel medical technologies VerIQ aims to create an integrated ecosystem where medtech innovators — from early-stage start-ups to multinational manufacturers — can design, launch, and execute clinical studies with unprecedented speed and scientific rigour.
The launch of VerIQ supports the UK governments’ ambitions to make the UK the destination of choice for health technology development and evaluation, accelerating the pathway for innovation adoption within the NHS and improving patient outcomes.
Warwick brings extensive experience in translational research and clinical trial design, supported by strong partnerships with NHS Trusts and national health technology evaluation programmes. Initial work through VerIQ will focus on orthopaedics and wider Medtech trials, combining Warwick’s academic leadership with the new spin-out’s dedicated operational capacity to streamline trial start-up, accelerate participant recruitment, and deliver consistent, high-quality data.
For more information please contact:
Joe Dupere, Chief Executive Officer, VerIQ Limited
Ann Baylis, Media and Communication Officer
ann.baylis@warwick.ac.uk / 07876 876937
About VerIQ Limited
VerIQ Limited is a UK-based Medtech clinical trial accelerator built to unlock faster, higher-quality clinical research. Through a coordinated network of pre-qualified trial sites, research nurses, and clinical investigators, VerIQ enables rapid study set-up, accelerated recruitment, and consistent data quality. Backed by a leadership team with deep expertise in complex and innovative trials, VerIQ partners with Medtech developers — from early innovators to global multinationals — to design and deliver clinical studies on time and on budget.
About the University of Warwick
Founded in 1965, the University of Warwick is a world-leading institution known for its commitment to era-defining innovation across research and education. A connected ecosystem of staff, students and alumni, the University fosters transformative learning, interdisciplinary collaboration and bold industry partnerships across state-of-the-art facilities in the UK and global satellite hubs. Here, spirited thinkers push boundaries, experiment and challenge convention to create a better world.